Blocking Tau Internalization: How Single-Domain Antibodies Could Help Combat Alzheimer's Disease

03·04·2025

Leveragen and Cell Signaling Technology Partner to Advance Reagent Antibody Innovation with Nanobody Technology

26·03·2025

Nanobody-Based pHluorin Tools: Advancing Synaptic Vesicle Research

25·03·2025

Revolutionizing Alzheimer's Detection: The Power of Nanobodies in Retinal and Blood Aβ Oligomer Detection

24·03·2025

Advancing Cryo-EM Structure Determination with Nanobody-Based Tools

20·03·2025

AstraZeneca to Acquire EsoBiotec for $1 Billion, Advancing In Vivo Cell Therapy

18·03·2025